Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
From - Diagnostic Testing & Emerging Technologies
Lung cancer-related testing is receiving a lot of attention, but recent results appear to show mixed benefits for these emerging tests…
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…
From - Diagnostic Testing & Emerging Technologies
The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of…
From - Diagnostic Testing & Emerging Technologies
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
Memorizing what actions to take in a fire situation is important, and reviewing this topic in October, National Fire Prevention Month, is both timely and…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
Finding information about the number of Laboratory Acquired Infections (LAIs) and other laboratory injuries in the United States is difficult…
By William A. Schiemann, Ph.D bio
Most leaders of companies today recognize the importance of having engaged people at work. Yet research from the Metrus Institute, Gallup, and others say that…
By Mike O'Brien bio
This is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws…
By Robert Mazer bio
The DOJ has announced two separate settlements involving claims for allegedly unnecessary special stains…